Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT07643610
Recruiting Observational

BEAT-SHOCK Registry

NCT07643610 · tracked via the Priya Life Science Switzerland tracker
Phase
Observational
Started
2025-10-01
Last updated
2026-06-11

Condition(s) studied

Cardiogenic ShockMyocardial Infarction (MI)Fulminant MyocarditisAcute Decompensated Heart FailureSevere Valvular DiseasePost-cardiotomyPerioperative Cardiogenic Shock

Investigational drug(s) / intervention(s)

no internvention

no internvention: This is a health data registry.

Study summary

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
* Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay * Age ≥18 years * Provision of written ICF * Clinical diagnosis of cardiogenic shock. * impaired organ perfusion due to primary cardiac dysfunction, * persistent systolic blood pressure (SBP) \<90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and * evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following: * Cold or clammy extremities * Altered mental status * Reduced urine output * Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring) * Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded Exclusion criteria: * Age \<18 years * Refusal to provide informed consent by the patient or their legally authorized representative

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Basel Basel Canton of Basel-City Recruiting

More University Hospital, Basel, Switzerland trials in Switzerland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07643610 on ClinicalTrials.gov ↗ ← All trials in Switzerland